{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"PIWORLD Investor Podcasts","title":"Deepmatter (DMTR) Overview & investment case","html":"","width":"100%","height":180,"duration":369,"description":"This video can be seen at: https://www.piworld.co.uk/2019/04/30/deepmatter-dmtr-overview-investment-case/\n \nDeepMatter Group plc is a technology company currently deploying its integrated software, hardware and machine learning enabled platform – DigitalGlassware™\nCEO Mark Warne presents an overview of the Group, it’s technology and the investment case.\nIntroduction – 00:17The technology – 01:07The roadmap – 02:38Infochem acquisition – 03:24The investment case – 04:29\nDeepmatter Group Plc, formerly Cronin Group Plc, is a United Kingdom-based company engaged in the digitization of chemical space coupled with chemical drug discovery, through its subsidiary, Cronin 3D Limited (Cronin 3D). Cronin 3D is a spin-out company, which is created to commercialize a platform technology to research and develop proprietary chemistry. The platform technology is intended to be used in the discovery, optimization and portable manufacture of small molecules and nano materials, with applications that are relevant in the pharmaceutical, formulation and materials science industries. Cronin 3D’s platform technology comprises a technology to implement a digital code for the discovery and manufacturing of molecules thereby digitizing chemistry, and is enabled through the application of 3D printing and related technologies for proprietary chemistry. Cronin 3D is engaged in developing the Chemputer, an autonomous universal digital synthesis engine.","thumbnail_url":"https://img.transistorcdn.com/oB5fNE4aIAia_YyTCKvE1PzrZQaD1Fjo_P7m7T9Aw_Y/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTJi/ODBiMzBmOGFhZWJi/MWEzYThkMzAyNmZm/MTdjZi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}